Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
ENSG00000276105 corresponds to "KCNQ1 overlapping transcript 1 conserved region 2" (KCNQ1OT1_2), which is annotated as a miscellaneous non-coding RNA rather than a protein-coding gene or canonical therapeutic target.[5] There is no evidence suggesting this entry encodes a receptor, enzyme, transporter, or established disease gene, and there is insufficient functional or therapeutic information in available reference databases. This target is not suitable for structuring as a therapeutic target (such as receptor, enzyme, transporter, etc.), and its main annotation is as a miscellaneous non-coding RNA transcript.[5]
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on KCNQ1 overlapping transcript 1 conserved region 2 (KCNQ1OT1_2).